|
|
|
|
Science Sparks @ ACTREC
|
 19 May 2025 |
Vol. No. 14 ; Issue No.683 |
|
|
|
|
|
|
Interesting Reads
|
|
Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Peña AM, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M, CheckMate 9DW investigators. Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW) (2025): An open-label, randomised, phase 3 trial. Lancet.
|
|
|
Video of the Week
|
|
| Hemophagocytic Lymphohisticocytosis( HLH): A Unique Disorder of Immune Regulation and what it may Teach Us about Human Immunology, Interferon Biology and Cancer |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2011, a study introduced the concept of ‘senescence surveillance’, wherein premalignant senescent hepatocytes are cleared through a tumour-antigen-directed immune response.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Immune control of metastatic cancer at the edge of the central nervous system
|
|
Nature, 14/05/2025
|
|
Leptomeningeal metastasis is a deadly consequence of cancer that creates an unusually inflamed environment around the brain and spinal cord. One of the inflammatory signalling molecules found in cerebrospinal fluid, interferon-γ, induces an antitumour immune response through an unexpected...
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
